These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 33646265)

  • 1. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
    Le Bert N; Clapham HE; Tan AT; Chia WN; Tham CYL; Lim JM; Kunasegaran K; Tan LWL; Dutertre CA; Shankar N; Lim JME; Sun LJ; Zahari M; Tun ZM; Kumar V; Lim BL; Lim SH; Chia A; Tan YJ; Tambyah PA; Kalimuddin S; Lye D; Low JGH; Wang LF; Wan WY; Hsu LY; Bertoletti A; Tam CC
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33646265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
    Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
    Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals.
    Tan AT; Lim JM; Le Bert N; Kunasegaran K; Chia A; Qui MD; Tan N; Chia WN; de Alwis R; Ying D; Sim JX; Ooi EE; Wang LF; Chen MI; Young BE; Hsu LY; Low JG; Lye DC; Bertoletti A
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections.
    Kennedy AE; Cook L; Breznik JA; Cowbrough B; Wallace JG; Huynh A; Smith JW; Son K; Stacey H; Ang J; McGeer A; Coleman BL; Larché M; Larché M; Hambly N; Nair P; Ask K; Miller MS; Bramson J; Levings MK; Nazy I; Svenningsen S; Mukherjee M; Bowdish DME
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
    Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
    Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.
    Lehmann AA; Kirchenbaum GA; Zhang T; Reche PA; Lehmann PV
    Front Immunol; 2021; 12():635942. PubMed ID: 34127926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    Shahbaz S; Xu L; Sligl W; Osman M; Bozorgmehr N; Mashhouri S; Redmond D; Perez Rosero E; Walker J; Elahi S
    J Immunol; 2021 Aug; 207(4):1099-1111. PubMed ID: 34312258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.
    Sen K; Datta S; Ghosh A; Jha A; Ahad A; Chatterjee S; Suranjika S; Sengupta S; Bhattacharya G; Shriwas O; Avula K; Kshatri J; Prasad P; Swain R; Parida AK; Raghav SK
    Front Immunol; 2021; 12():733539. PubMed ID: 34899693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
    Mazzoni A; Maggi L; Capone M; Spinicci M; Salvati L; Colao MG; Vanni A; Kiros ST; Mencarini J; Zammarchi L; Mantengoli E; Menicacci L; Caldini E; Romagnani S; Liotta F; Morettini A; Rossolini GM; Bartoloni A; Cosmi L; Annunziato F
    Eur J Immunol; 2020 Dec; 50(12):2013-2024. PubMed ID: 33080068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.
    Stanczak MA; Sanin DE; Apostolova P; Nerz G; Lampaki D; Hofmann M; Steinmann D; Krohn-Grimberghe M; Thimme R; Mittler G; Waller CF; Pearce EJ; Pearce EL
    Nat Commun; 2021 Apr; 12(1):2133. PubMed ID: 33837219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.
    Caicedo MS; Flores V; Padilla A; Lauryn S; Jacobs JJ; Hallab NJ
    J Orthop Surg Res; 2021 Jun; 16(1):415. PubMed ID: 34193239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
    Tripathy AS; Vishwakarma S; Trimbake D; Gurav YK; Potdar VA; Mokashi ND; Patsute SD; Kaushal H; Choudhary ML; Tilekar BN; Sarje P; Dange VS; Abraham P
    Arch Virol; 2021 Dec; 166(12):3301-3310. PubMed ID: 34554303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
    Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study.
    Casado JL; Häemmerle J; Vizcarra P; Velasco H; Velasco T; Fernandez-Escribano M; Vallejo A
    Clin Microbiol Infect; 2021 Jun; 27(6):916.e1-916.e4. PubMed ID: 33667629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4
    Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S
    J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and the role of cytokines in this disease.
    Hasanvand A
    Inflammopharmacology; 2022 Jun; 30(3):789-798. PubMed ID: 35505267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.
    Long QX; Tang XJ; Shi QL; Li Q; Deng HJ; Yuan J; Hu JL; Xu W; Zhang Y; Lv FJ; Su K; Zhang F; Gong J; Wu B; Liu XM; Li JJ; Qiu JF; Chen J; Huang AL
    Nat Med; 2020 Aug; 26(8):1200-1204. PubMed ID: 32555424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.